2020.09.14
License Agreement Has Been Entered into with Elixirgen Scientific, Inc.
License-Out
We have executed a non-exclusive license agreement with Elixirgen Scientific, Inc. (Baltimore, MD, U.S.A.) for allowing them to sell iPS cell-derived cells and provide services using the iPS cell-derived cells for user's research purposes under the patents on iPS cell technologies licensed to us by Kyoto University.